Basic info
Industry
biotechnology research
Sectors
infectious diseases
Innovation Management
Vaccines
HRV
HSV-2
Lassa
parainfluenza
HSV-1
cytomegalovirus
drug discovery
DENV
adenovirus
antibodies
HBV
antiviral assays
neutralization
CMV
Health Care
RSV
AAV
plaque assay
Pseudovirus
antiviral
human immunodeficiency virus
HCV
LASV
plaque reduction assay
respiratory syncytial virus
Ebola
Life Science
influenza
Biotechnology
CRO
retrovirus
LCMV
antiviral services
Diagnostics
HCMV
virus
Zika
herpes
EBOV
coronavirus
hepatitis
rhinovirus
dengue
flu
chikungunya
ZIKV
Health Diagnostics
vaccine
anti-viral
HIV
virology
Influenza
Antivirals
neutralization assay
PRA
poliovirus
Date founded
2008
Funding rounds raised
Total raised
$3M
from 1 investors over 1 rounds
R
RetroVirox Inc. raised $3M on March 12, 2015
Investors: National Institutes of Health